Dermatology and Venereology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Dermatology Department, Armed Forces College of Medicine, Cairo, Egypt.
Int J Dermatol. 2018 Sep;57(9):1135-1144. doi: 10.1111/ijd.14075. Epub 2018 Jun 16.
Multiple treatment modalities were introduced for treatment of hidradenitis suppurativa (HS) but mostly with unsatisfactory results.
In this prospective randomized right-left intra-individual controlled study, we studied the safety and efficacy of combined treatment with fractional CO laser and long pulsed Nd : YAG (1064 nm) laser in treatment of HS.
Twenty adult patients with HS were randomized into this study. The patients were randomly allocated to receive four laser sessions with 2 weeks interval. Control side received long pulsed Nd : YAG laser (1064 nm) only, and the other side (combined treatment side) received combined fractional CO laser and long pulsed Nd : YAG (1064 nm) laser. Patients were clinically and histopathologically evaluated 2 weeks post treatment. Recurrence was evaluated 3 months post treatment. Outcome was clinically evaluated by physician global assessment (PGA), 10-point visual analog scale for patient's satisfaction, and side effects.
Statistically significant higher improvement and patient's satisfaction was observed in combined treatment side compared with control side (P = 0.011, 0.048 respectively). Absence of recurrence was achieved by 55% of sides receiving combined treatment and 35% of control sides.
Combination of fractional CO laser and long pulsed Nd : YAG (1064 nm) laser in treatment of HS had higher improvement and patient's satisfaction together with lower recurrence compared with long pulsed Nd : YAG (1064 nm) laser alone. Better results could be achieved with low PGA, non-obese populations, and absence of surgeries for the lesions.
多种治疗方法被引入用于治疗化脓性汗腺炎(HS),但大多效果不理想。
在这项前瞻性随机左右个体内对照研究中,我们研究了联合应用分束 CO2 激光和长脉冲 Nd:YAG(1064nm)激光治疗 HS 的安全性和疗效。
20 例成人 HS 患者被随机纳入本研究。患者随机分为 4 组,每组间隔 2 周接受 4 次激光治疗。对照组仅接受长脉冲 Nd:YAG 激光(1064nm)治疗,另一侧(联合治疗组)接受联合分束 CO2 激光和长脉冲 Nd:YAG(1064nm)激光治疗。治疗后 2 周进行临床和组织病理学评估,治疗后 3 个月进行复发评估。疗效通过医生总体评估(PGA)、患者满意度 10 分视觉模拟量表和不良反应进行临床评估。
与对照组相比,联合治疗组在改善程度和患者满意度方面均有统计学意义(P=0.011,0.048)。联合治疗组 55%的治疗侧和对照组 35%的治疗侧无复发。
与单独使用长脉冲 Nd:YAG(1064nm)激光相比,联合应用分束 CO2 激光和长脉冲 Nd:YAG(1064nm)激光治疗 HS 可获得更高的改善和患者满意度,同时复发率更低。PGA 较低、非肥胖人群和无手术治疗病变可获得更好的疗效。